Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1

INTRODUCTION: Phaeochromocytomas/paragangliomas (PHAEO/PG) are linked to hereditary syndromes including Neurofibromatosis type 1 (NF-1). Current guidelines do not recommend biochemical screening for PHAEO/PG in asymptomatic or normotensive patients with NF-1. This strategy may miss preventable morbi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sharefi, A, Perros, P, James, R A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198184/
https://www.ncbi.nlm.nih.gov/pubmed/30120202
http://dx.doi.org/10.1530/EC-18-0208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198184/
https://www.ncbi.nlm.nih.gov/pubmed/30120202
http://dx.doi.org/10.1530/EC-18-0208

Ejemplares similares